Wyeth Touts Tygacil As First Global NDA Submission
This article was originally published in The Pink Sheet Daily
Executive Summary
The first-in-class glycylcycline antibiotic could be a monotherapy option in the treatment of complicated infections, Wyeth says. The company would likely detail the injectable alongside its antibiotic Zosyn.